Afatinib-induced Interstitial Lung Disease Successfully Treated with Corticosteroids: Case Report and Review of the Literature

The first-line treatment for advanced epidermal growth factor receptor (EGFR) mutation positive non-small cell lung cancer (NSCLC) includes the use of afatinib and other EGFR tyrosine kinase inhibitors (EGFR-TKIs). While generally well tolerated, a small subset of patients will develop drug-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Jobe, Amanda L, Ahonen, Kyle T, Poplin, Victoria, Rao, Sunitha, Mohyuddin, Ghulam Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093270/
https://www.ncbi.nlm.nih.gov/pubmed/30123727
http://dx.doi.org/10.7759/cureus.2805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093270/
https://www.ncbi.nlm.nih.gov/pubmed/30123727
http://dx.doi.org/10.7759/cureus.2805

Ejemplares similares